Caricamento...

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors

Patients with autoimmune rheumatic diseases (ARD) have an increased risk for tuberculosis (TB). The use of tumor necrosis factor inhibitors (TNFi) and glucocorticoids in these patients has been associated with an increased prevalence of latent TB reactivation. Over the last few years, several biolog...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Adv Musculoskelet Dis
Autori principali: Evangelatos, Gerasimos, Koulouri, Vasiliki, Iliopoulos, Alexios, Fragoulis, George E
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7309385/
https://ncbi.nlm.nih.gov/pubmed/32612710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20930116
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !